Free Trial

Dogwood Therapeutics (DWTX) SEC Filings & 10K Form

Dogwood Therapeutics logo
$4.83 -0.06 (-1.23%)
Closing price 03:58 PM Eastern
Extended Trading
$4.92 +0.09 (+1.86%)
As of 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Dogwood Therapeutics SEC Filings

DateFilerForm TypeView
07/01/2025
12:52 PM
De La Rosa Abel (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
12:56 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Walsh Angela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
12:58 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Keefer David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:00 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Duncan Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:02 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Thomas John C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:05 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Grosswald Ralph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:07 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Whitley Richard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:11 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Gendreau Roger Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:01 PM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/24/2025
9:15 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
10:57 AM
De La Rosa Abel (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
10:59 AM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Thomas John C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
11:02 AM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Keefer David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
11:04 AM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Whitley Richard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
11:15 PM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form EFFECT
05/23/2025
4:25 PM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/09/2025
10:28 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
8:20 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
1:08 PM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form ARS
04/30/2025
7:00 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form DEF 14A
04/03/2025
8:10 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:44 PM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
7:19 PM
Conjoint Inc. (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/17/2025
8:11 PM
Dogwood Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Sealbond Ltd (Filed by)
Form SCHEDULE 13D/A
03/17/2025
8:07 PM
CK Life Sciences Intl Inc (0001297567) (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:53 PM
Dogwood Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Orca Capital AG (Filed by)
Form SCHEDULE 13G/A
03/17/2025
4:49 PM
Dogwood Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Orca Capital AG (Filed by)
Form SCHEDULE 13G
03/14/2025
10:47 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2025
9:32 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 424B5
03/12/2025
8:00 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
8:30 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K/A
11/21/2024
8:15 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:15 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:15 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
8:25 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:29 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Toh Kean Meng Melvin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2024
3:30 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Yu Ying Choi Alan Abel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2024
3:29 PM
CK Life Sciences Intl Inc (0001297567) (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Sealbond Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2024
3:19 PM
Sealbond Ltd (Filed by)
Virios Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Form SC 13D
10/07/2024
7:06 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form DEFA14A
10/07/2024
7:02 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Billionaires are piling into this gold investment (Ad)

Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scrambling to buy gold coins and bars. But some savvy investors have used a different way to profit from gold bull runs — a special investment with a long history of making 13 times … 21 times … 157 times … even a surprising 1,000 times more than physical gold.

Click here to see how to make the most out of this historic gold bull market.
08/09/2024
9:15 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
8:30 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DWTX) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners